Cargando…
Organ dysfunction, injury, and failure in cardiogenic shock
BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patient...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308671/ https://www.ncbi.nlm.nih.gov/pubmed/37386552 http://dx.doi.org/10.1186/s40560-023-00676-1 |
_version_ | 1785066294488334336 |
---|---|
author | Shirakabe, Akihiro Matsushita, Masato Shibata, Yusaku Shighihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Kiuchi, Kazutaka Asai, Kuniya |
author_facet | Shirakabe, Akihiro Matsushita, Masato Shibata, Yusaku Shighihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Kiuchi, Kazutaka Asai, Kuniya |
author_sort | Shirakabe, Akihiro |
collection | PubMed |
description | BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. CONCLUSIONS: Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS. |
format | Online Article Text |
id | pubmed-10308671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103086712023-06-30 Organ dysfunction, injury, and failure in cardiogenic shock Shirakabe, Akihiro Matsushita, Masato Shibata, Yusaku Shighihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Kiuchi, Kazutaka Asai, Kuniya J Intensive Care Review BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. CONCLUSIONS: Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS. BioMed Central 2023-06-29 /pmc/articles/PMC10308671/ /pubmed/37386552 http://dx.doi.org/10.1186/s40560-023-00676-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Shirakabe, Akihiro Matsushita, Masato Shibata, Yusaku Shighihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Kiuchi, Kazutaka Asai, Kuniya Organ dysfunction, injury, and failure in cardiogenic shock |
title | Organ dysfunction, injury, and failure in cardiogenic shock |
title_full | Organ dysfunction, injury, and failure in cardiogenic shock |
title_fullStr | Organ dysfunction, injury, and failure in cardiogenic shock |
title_full_unstemmed | Organ dysfunction, injury, and failure in cardiogenic shock |
title_short | Organ dysfunction, injury, and failure in cardiogenic shock |
title_sort | organ dysfunction, injury, and failure in cardiogenic shock |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308671/ https://www.ncbi.nlm.nih.gov/pubmed/37386552 http://dx.doi.org/10.1186/s40560-023-00676-1 |
work_keys_str_mv | AT shirakabeakihiro organdysfunctioninjuryandfailureincardiogenicshock AT matsushitamasato organdysfunctioninjuryandfailureincardiogenicshock AT shibatayusaku organdysfunctioninjuryandfailureincardiogenicshock AT shighiharashota organdysfunctioninjuryandfailureincardiogenicshock AT nishigoorisuguru organdysfunctioninjuryandfailureincardiogenicshock AT sawatanitomofumi organdysfunctioninjuryandfailureincardiogenicshock AT kiuchikazutaka organdysfunctioninjuryandfailureincardiogenicshock AT asaikuniya organdysfunctioninjuryandfailureincardiogenicshock |